Microbiological Characteristics of Kidney Stones in Patients With Urolithiasis
V. N. Pavlov,
A. M. Pushkarev,
V. L. Medvedev,
V. V. Sergeev,
V. V. Churbakov,
I. A. Gimranova,
G. R. Gazizullina,
L. R. Khakimova,
E. R. Akramova,
D. Z. Valiakhmetova,
S. Sh. Sabirzyanov https://doi.org/10.35401/2541-9897-2024-9-2-129-134
Abstract
In recent years, there has been an upward trend in the urolithiasis incidence worldwide and an increase in the recurrence of stone formation. Urolithiasis prevalence rates range from 1% to 20%. In some countries, there is an increase in rates up to 37%. Stones are classified into those caused by infections, non infectious causes, and genetic diseases. Alteration in urine microbiome plays a significant role in the infection stone formation. Our objective was to review the current literature on the role of bacteria in the formation of kidney concrements. The gained knowledge could be used to explore new possibilities and improve the understanding of stone formation. We analyzed articles on the composition of the urine microbiome and kidney stones.
About the Authors
V. N. Pavlov
Bashkir State Medical University
Russian Federation
Russian Federation
Valentin N. Pavlov, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head of the Urology and Oncology Department
Ufa
A. M. Pushkarev
Bashkir State Medical University
Russian Federation
Russian Federation
Aleksey M. Pushkarev, Dr. Sci. (Med.), Professor at the Urology and Oncology Department
Ufa
V. L. Medvedev
Kuban State Medical University
Russian Federation
Russian Federation
Vladimir L. Medvedev, Dr. Sci. (Med.), Professor, Head of the Urology Department, Kuban State Medical University; Deputy Chief Physician for Urology, Head of the Regional Uronephrology Center, Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1
Krasnodar
V. V. Sergeev
Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Vladimir V. Sergeev, Cand. Sci. (Med.), Head of the Urology Unit No. 1
Krasnodar
V. V. Churbakov
Regional Clinical Hospital No. 2
Russian Federation
Russian Federation
Vasiliy V. Churbakov, Urologist, Urology Unit No. 1
Krasnodar
I. A. Gimranova
Bashkir State Medical University
Russian Federation
Russian Federation
Irina A. Gimranova, Cand. Sci. (Med.), Head of the Department of Fundamental and Applied Microbiology
ulitsa Lenina 3, Ufa, 450077
G. R. Gazizullina
Bashkir State Medical University
Russian Federation
Russian Federation
Gulnara R. Gazizullina, Head of the Laboratory of Human Microbiome
Ufa
L. R. Khakimova
Bashkir State Medical University
Russian Federation
Russian Federation
Liliya R. Khakimova, Cand. Sci. (Bio.), Associate Professor at the Department of Fundamental and Applied Microbiology
Ufa
E. R. Akramova
Bashkir State Medical University
Russian Federation
Russian Federation
Elina R. Akramova, 1st Year Master’s Student (Biology)
Ufa
D. Z. Valiakhmetova
Bashkir State Medical University
Russian Federation
Russian Federation
Diana Z. Valiakhmetova, 1st Year Master’s Student (Biology)
Ufa
S. Sh. Sabirzyanov
Bashkir State Medical University
Russian Federation
Russian Federation
Sabir Sh. Sabirzyanov, Resident, Urology and Oncology Department
Ufa
References
1. Russian Society of Urology. Clinical Guidelines. Urolithiasis. Russian Society of Urologists; 2019. (In Russ.).
2. Kaprin AD, Apolikhin OI, Sivkov AV, et al. The incidence of urolithiasis in the Russian Federation from 2005 to 2020. Experimental and Clinical Urology. 2022;15(2):10–17. (In Russ.). https://doi.org/10.29188/2222-8543-2022-15-2-10-17
3. Türk C, Neisius A, Petrik A, et al. EAU Guidelines on Urolithiasis. European Association of Urology; 2020.
4. Thorleifsson G, Holm H, Edvardsson V, et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet. 2009;41(8):926–930. PMID: 19561606. https://doi.org/10.1038/ng.404
5. Yang Y, Miao L, Lu Y, Wang S. The genetics of urinary microbiome, an exploration of the trigger in calcium oxalate stone. Front Genet. 2023;14:1260278. PMID: 37854058. PMCID: PMC10579592. https://doi.org/10.3389/fgene.2023.1260278
6. Foley KF, Boccuzzi L. Urine calcium: laboratory measurement and clinical utility. Laboratory Medicine. 2010;41(11):683– 686. https://doi.org/10.1309/lm9so94znbhedntm
7. Laube N, Pullmann M, Hergarten S, Schmidt M, Hesse A. The alteration of urine composition due to stone material present in the urinary tract. Eur Urol. 2003;44(5):595–599. PMID: 14572760. https://doi.org/10.1016/s0302-2838(03)00365-8
8. Gao H, Lin J, Xiong F, Yu Z, Pan S, Huang Y. Urinary microbial and metabolomic profiles in kidney stone disease. Front Cell Infect Microbiol. 2022;12:953392. PMID: 36132987. PMCID: PMC9484321. https://doi.org/10.3389/fcimb.2022.953392
9. Ye Z, Zeng G, Yang H, et al. The status and characteristics of urinary stone composition in China. BJU Int. 2020;125(6):801– 809. PMID: 30958622. https://doi.org/10.1111/bju.14765
10. Robinson TE, Hughes EAB, Wiseman OJ, Stapley SA, Cox SC, Grover LM. Hexametaphosphate as a potential therapy for the dissolution and prevention of kidney stones. J Mater Chem B. 2020;8(24):5215–5224. PMID: 32436557. https://doi.org/10.1039/d0tb00343c
11. Xie J, Huang JS, Huang XJ, et al. Profiling the urinary microbiome in men with calcium-based kidney stones. BMC Microbiol. 2020;20(1):41. PMID: 32111156. PMCID: PMC7049185. https://doi.org/10.1186/s12866-020-01734-6
12. Pazos Pérez F. Uric acid renal lithiasis: new concepts. Contrib Nephrol. 2018;192:116–124. PMID: 29393127. https://doi.org/10.1159/000484286
13. Moussa M, Papatsoris AG, Abou Chakra M, Moussa Y. Update on cystine stones: current and future concepts in treatment. Intractable Rare Dis Res. 2020;9(2):71–78. PMID: 32494553. PMCID: PMC7263987. https://doi.org/10.5582/irdr.2020.03006
14. Hung JA, Li CH, Geng JH, Wu DW, Chen SC. Dyslipidemia increases the risk of incident kidney stone disease in a large Taiwanese population follow-up study. Nutrients. 2022;14(7):1339. PMID: 35405952. PMCID: PMC9000795. https://doi.org/10.3390/nu14071339
15. Styazhkina SN, Tokareva VY, Gilfanov AM. Urolithiasis disease. Coral stone of the left kidney. Clinical case. Stolitsa nauki. 2020;(4):150–157. (In Russ.).
16. DornbierRA, Bajic P, Van Kuiken M, et al. The microbiome of calcium-based urinary stones. Urolithiasis. 2020;48(3):191–199. PMID: 31240349. https://doi.org/10.1007/s00240-019-01146-w
17. Schwaderer AL, Wolfe AJ. The association between bacteria and urinary stones. Ann Transl Med. 2017;5(2):32. PMID: 28217697. PMCID: PMC5300853. https://doi.org/10.21037/atm.2016.11.73
18. Sivaguru M, Saw JJ, Williams JC Jr, et al. Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep. 2018;8(1):13731. PMID: 30213974. PMCID: PMC6137216. https://doi.org/10.1038/s41598-018-31890-9
19. Sivaguru M, Saw JJ, Wilson EM, et al. Human kidney stones: a natural record of universal biomineralization. Nat Rev Urol. 2021;18(7):404–432. PMID: 34031587. https://doi.org/10.1038/s41585-021-00469-x
20. Zampini A, Nguyen AH, Rose E, Monga M, Miller AW. Defining dysbiosis in patients with urolithiasis. Sci Rep. 2019;9(1):5425. PMID: 30932002. PMCID: PMC6443657. https:// doi.org/10.1038/s41598-019-41977-6
21. Lemberger U, Pjevac P, Hausmann B, et al. The microbiome of kidney stones and urine of patients with nephrolithiasis. Urolithiasis. 2023;51(1):27. PMID: 36596939. PMCID: PMC9810570. https://doi.org/10.1007/s00240-022-01403-5
22. Li JKM, Chiu PKF, Ng CF. The impact of microbiome in urological diseases: a systematic review. Int Urol Nephrol. 2019;51(10):1677–1697. PMID: 31301004. https://doi.org/10.1007/s11255-019-02225-y
23. Flannigan RK, Battison A, De S, et al. Evaluating factors that dictate struvite stone composition: a multi-institutional clinical experience from the EDGE Research Consortium. Can Urol Assoc J. 2018;12(4):131–136. PMID: 29319486. PMCID: PMC5905542. https://doi.org/10.5489/cuaj.4804
24. Galán-Llopis JA, Sánchez-Pellicer P, Navarro-López V. Role of microbiome in kidney stone disease. Curr Opin Urol. 2023;33(2):84–89. PMID: 36210763. https://doi.org/10.1097/MOU.0000000000001051
25. Jung HD, Cho S, Lee JY. Update on the effect of the urinary microbiome on urolithiasis. Diagnostics (Basel). 2023;13(5):951. PMID: 36900094. PMCID: PMC10001284. https://doi.org/10.3390/diagnostics13050951
26. Daudon M, Dessombz A, Frochot V, et al. Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis. Comptes Rendus Chimie. 2016;19(11–12):1470–1491. https://doi.org/10.1016/j.crci.2016.05.008
27. Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. Recent advances on the mechanisms of kidney stone formation (review). Int J Mol Med. 2021;48(2):149. PMID: 34132361. PMCID: PMC8208620. https://doi.org/10.3892/ijmm.2021.4982
28. Hong SY, Xia QD, Yang YY, et al. The role of microbiome: a novel insight into urolithiasis. Crit Rev Microbiol. 2023;49(2):177–196. PMID: 35776498. https://doi.org/10.1080/1040841X.2022.2045899
29. Hobbs T, Schultz LN, Lauchnor EG, Gerlach R, Lange D. Evaluation of biofilm induced urinary infection stone formation in a novel laboratory model system. J Urol. 2018;199(1):178–185. PMID: 28827106. https://doi.org/10.1016/j.juro.2017.08.083
30. Barr-Beare E, Saxena V, Hilt EE, et al. The interaction between Enterobacteriaceae and calcium oxalate deposits. PLoS One. 2015;10(10):e0139575. PMID: 26448465. PMCID: PMC4598009. https://doi.org/10.1371/journal.pone.0139575
31. Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, et al. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012;27(11):4125–4130. PMID: 22461670. https://doi.org/10.1093/ndt/gfs057
32. Chutipongtanate S, Sutthimethakorn S, Chiangjong W, Thongboonkerd V. Bacteria can promote calcium oxalate crystal growth and aggregation. J Biol Inorg Chem. 2013;18(3):299–308. Published correction appears in J Biol Inorg Chem. 2013;18(4):485– 486. PMID: 23334195. https://doi.org/10.1007/s00775-012-0974-0
33. Kanlaya R, Naruepantawart O, Thongboonkerd V. Flagellum is responsible for promoting effects of viable Escherichia coli on calcium oxalate crystallization, crystal growth, and crystal aggregation. Front Microbiol. 2019;10:2507. PMID: 31749785. PMCID: PMC6848068. https://doi.org/10.3389/fmicb.2019.02507
34. Saw JJ, Sivaguru M, Wilson EM, et al. In vivo entombment of bacteria and fungi during calcium oxalate, brushite, and struvite urolithiasis. Kidney360. 2020;2(2):298–311. PMID: 35373025. PMCID: PMC8740987. https://doi.org/10.34067/KID.0006942020
35. Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones--pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014;11(6):333–341. Published correction appears in Nat Rev Urol. 2014;11(6):page after 341. PMID: 24818849. https://doi.org/10.1038/nrurol.2014.99
36. Miller AW, Penniston KL, Fitzpatrick K, Agudelo J, Tasian G, Lange D. Mechanisms of the intestinal and urinary microbiome in kidney stone disease. Nat Rev Urol. 2022;19(12):695–707. PMID: 36127409. https://doi.org/10.1038/s41585-022-00647-5
37. Hong SY, Yang YY, Xu JZ, Xia QD, Wang SG, Xun Y. The renal pelvis urobiome in the unilateral kidney stone patients revealed by 2bRAD-M. J Transl Med. 2022;20(1):431. PMID: 36153619. PMCID: PMC9509602. https://doi.org/10.1186/s12967-022-03639-6
38. Al KF, Joris BR, Daisley BA, et al. Multi-site microbiota alteration is a hallmark of kidney stone formation. Microbiome. 2023;11(1):263. PMID: 38007438. PMCID: PMC10675928. https://doi.org/10.1186/s40168-023-01703-x
39. Liu F, Zhang N, Wu Y, et al. The pelvis urinary microbiome in patients with kidney stones and clinical associations. BMC Microbiol. 2020;20(1):336. PMID: 33153435. PMCID: PMC7643416. https://doi.org/10.1186/s12866-020-01992-4
Review
For citations:
Pavlov V.N., Pushkarev A.M., Medvedev V.L., Sergeev V.V., Churbakov V.V., Gimranova I.A., Gazizullina G.R., Khakimova L.R., Akramova E.R., Valiakhmetova D.Z., Sabirzyanov S.Sh. Microbiological Characteristics of Kidney Stones in Patients With Urolithiasis. Innovative Medicine of Kuban. 2024;(2):129-134. (In Russ.) https://doi.org/10.35401/2541-9897-2024-9-2-129-134
Views:
611
Email this article 
